Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03507777 · ClinicalTrials.gov registry record · NA
ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI)
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 2,487
- Enrollment target
NCT03507777 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 2,487 participants.
The verdict
NCT03507777, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,487 participants
- Enrollment target
Study Summary
The objective of this prospective, single-blind clinical investigation is to demonstrate the superiority of an Optical Coherence Tomography (OCT)-guided stent implantation strategy as compared to an angiography-guided stent implantation strategy in achieving larger post-PCI lumen dimensions and improving clinical cardiovascular outcomes in patients with high-risk clinical characteristics and/or with high-risk angiographic lesions.
Interventions
- DEVICE Coronary PCI guided by OCT
- DEVICE Coronary PCI guided by Angiography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,487 participants |
| Start Date | 2018-05-17 |
| Est. Completion | 2023-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03507777
The ClinicalTrials.gov registry entry for NCT03507777 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,487 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Coronary PCI guided by OCT is the first listed.
NCT03507777 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03507777 about?
NCT03507777 is a clinical study titled "ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI)". The objective of this prospective, single-blind clinical investigation is to demonstrate the superiority of an Optical Coherence Tomography (OCT)-guided stent implantation strategy as compared to an angiography-guided stent implantation strategy in achieving larger post-PCI lumen dimensions and impr...
What is the current status of trial NCT03507777?
This trial is currently completed. It is a NA study. The enrollment target is 2,487 participants. The study started on 2018-05-17. Estimated completion is 2023-02-28.
What interventions are being tested in trial NCT03507777?
The interventions under investigation include: Coronary PCI guided by OCT (DEVICE), Coronary PCI guided by Angiography (DEVICE).
Who is sponsoring clinical trial NCT03507777?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.